文献速递临床试验与 GCP

直肠癌保肛术后排便功能障碍的远程精准饮食管理干预:随机对照试验研究方案

Remote precise diet management intervention of defecation dysfunction among patients with rectal cancer after the sphincter-saving surgery: a study protocol for a randomized controlled trial.
PubMed 文献 · Trials · 2025-10-22

本研究为单中心、前瞻性、随机对照、非盲试验,纳入直肠癌保肛术后患者,随机分为两组。干预组接受远程精准饮食管理干预方案,对照组接受内容相同的饮食手册及本院常规术后饮食与肠道症状管理宣教。主要结局为保肛术后低位前切除综合征(LARS)发生率,次要结局为生活质量与饮食摄入,于基线、第3个月和第6个月采集数据,采用广义估计方程(GEE)评估干预总体效果。

要点

  • 干预组接受远程精准饮食管理干预,含一对一饮食指导、书面手册、app辅助饮食记录与计划,以及每2周3次远程巩固指导与监督。
  • 对照组接受与远程精准饮食管理方案内容相同的饮食手册,并接受本院常规提供的术后饮食与肠道症状管理宣教。
  • 主要结局为保肛术后LARS发生率,次要结局为生活质量与饮食摄入,分别采用LARSS、EORTC-QLQ-C30问卷和食物频率问卷(FFQ)评估。

核心结论

  • 研究旨在评估远程精准饮食管理干预方案对保肛术后排便功能障碍患者的效果,为临床实施可行的饮食管理提供理论依据。
  • 研究结果有望找到控制排便功能障碍的有效方法,最终改善保肛术后患者的生活质量。

研究设计与样本

  • 本研究为单中心、前瞻性、随机对照、非盲试验,在三甲综合医院纳入直肠癌保肛术后患者并随机分为两组。
  • 干预自出院开始持续至术后6个月,数据于基线、第3个月和第6个月共采集三次。
  • 采用广义估计方程(GEE)评估干预对LARS发生率、生活质量和饮食摄入的总体效果。

主要发现

  • 研究方案阶段尚未报告干预效果数据。

关键数值与推荐

  • 主要结局为保肛术后LARS发生率,采用低位前切除综合征评分(LARSS)评估。
  • 次要结局为生活质量和饮食摄入,分别采用EORTC-QLQ-C30问卷和食物频率问卷(FFQ)评估。
  • 干预组方案包括一对一饮食指导、书面手册、app辅助饮食记录与计划,以及每2周3次远程巩固指导与监督。

临床怎么用

  • 对照组接受与远程精准饮食管理方案内容相同的饮食手册,并接受本院常规术后饮食与肠道症状管理宣教。
  • 干预组在出院至术后6个月期间接受远程精准饮食管理干预。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Different degrees of defecation dysfunction have emerged after the sphincter-saving surgery, which has made a significant influence on the quality of life of patients. Although diet adjustments were shown to be important for the management of defecation dysfunction, studies on the dietary management measures for defecation dysfunction after the sphincter-saving surgery are still scarce. This study aims to evaluate the effects of a "remote precise diet management intervention program" on patients with defecation dysfunction after the sphincter-saving surgery, providing a theoretical basis for clinical implementation of feasible diet management, and ultimately improving the quality of life of patients after the sphincter-saving surgery. METHODS: This study will be a single-center, prospective, randomized controlled, non-blind trial involving rectal cancer patients after sphincter-saving surgery in a three tertiary general hospital who will be randomized into two groups. The intervention group will apply the "remote precise diet management intervention program" including one-on-one dietary instructions, a written booklet, app-assisted dietary recording and planning, and three times remote consolidating instructions and supervision every 2 weeks. The control group will receive a booklet that contains the same information as that provided in the "remote precise diet management program" and receive the standard counseling that is routinely provided by this hospital about the postoperative diet and Management of bowel symptoms. The intervention will begin from discharge until 6 months after surgery. The primary outcome will be the incidence of LARS after the sphincter-saving surgery. The secondary outcome is the quality of life and the dietary intake of participants after surgery. The occurrence of LARS will be evaluated by the Low Anterior Resection Syndrome Score (LARSS), quality of life, and dietary intake will be separately evaluated by the EORTC-QLQ-C30 questionnaire and Food Frequency Questionnaire(FFQ). Data will be collected three times: the baseline, 3rd month, and 6th month. Statistical analysis will be used to compare the outcomes between groups. Generalized estimating equations (GEEs) will be performed to evaluate the overall effect of the intervention on the incidence of LARS, quality of life, and dietary intake. DISCUSSION: The "remote precise diet management intervention program" in this study is designed with the characteristics of scientificity, precision, and feasibility aiming at controlling the bowel symptoms of patients after the sphincter-saving surgery. The findings of the study will provide a theoretical basis for the clinical implementation of feasible diet management, find effective ways to control defecation dysfunction, and ultimately improve the quality of life of patients after the sphincter-saving surgery. TRIAL REGISTRATION: This study has been registered in the Chinese Clinical Trial Registry on March 22nd 2024 (the registration number is ChiCTR2400082167).

来源:Trials,查看原文。版权归原作者所有。

引用

  1. Liu W, Xu JM, Zhu A, et al. Remote precise diet management intervention of defecation dysfunction among patients with rectal cancer after the sphincter-saving surgery: a study protocol for a randomized controlled trial. Trials. 2025. PMID: 41126308. doi:10.1186/s13063-025-09110-3

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。